Season One - Episode 1: The last few years have shown a major change in first-line management of restless legs. In this podcast, Dr. Michael Silber discusses why gabapentinoids are now first-line therapy rather than dopamine agonists, how they are used, and whether there is any role still for the dopaminergic drugs.
0:07 Welcome to Mayo Clinic Sleep Medicine Podcast
0:40 Introduction to Episode One
1:27 What prompted the shift away from Dopamine Agonists as a first line treatment?
8:20 When would you not use Alpha 2 Delta Ligands?
11:14 What precautions would you take if you were now going to try a dopamine agonist and which one would you use?
16:28 Does carbidopa/levodopa have a role in treatment of restless legs syndrome (RLS)?
17:38 Final Messages
From Mayo Clinic to your inbox, sign-up for free: mayocl.in/3e71zfi
Visit Mayo Clinic: www.mayoclinic...
Like Mayo Clinic on Facebook: / mayoclinic
Follow Mayo Clinic on Instagram: / mayoclinic
Follow Mayo Clinic on X, formerly Twitter: x.com/MayoClinic
Follow Mayo Clinic on Threads: www.threads.ne...